Merck (MRK) Non Operating Income (2016 - 2025)
Merck (MRK) has disclosed Non Operating Income for 17 consecutive years, with -$432.0 million as the latest value for Q4 2025.
- Quarterly Non Operating Income fell 240.16% to -$432.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$152.0 million through Dec 2025, down 684.62% year-over-year, with the annual reading at -$151.0 million for FY2025, 729.17% down from the prior year.
- Non Operating Income for Q4 2025 was -$432.0 million at Merck, down from $238.0 million in the prior quarter.
- The five-year high for Non Operating Income was $455.0 million in Q1 2021, with the low at -$708.0 million in Q1 2022.
- Average Non Operating Income over 5 years is -$37.4 million, with a median of -$17.5 million recorded in 2024.
- The sharpest move saw Non Operating Income skyrocketed 740.85% in 2021, then crashed 525.24% in 2022.
- Over 5 years, Non Operating Income stood at $334.0 million in 2021, then crashed by 77.54% to $75.0 million in 2022, then tumbled by 204.0% to -$78.0 million in 2023, then plummeted by 62.82% to -$127.0 million in 2024, then crashed by 240.16% to -$432.0 million in 2025.
- According to Business Quant data, Non Operating Income over the past three periods came in at -$432.0 million, $238.0 million, and $7.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.